LncRNA | Target | Samples | Function | Year | Refs. |
---|---|---|---|---|---|
H19 | miR-29b-3p/ PGRN | 185 NT* HCT116, HT29, SW620, and SW480 cell lines | Induced EMT | 2018 | Ding et al. [22] |
AGAP2-AS1 | miR-4668-3p/ SRSF1 | SW620, HT-29, and HCT8 cell lines | Induced EMT | 2020 | Li et al. [26] |
ATB | CDH1 | 60 NT, 50 patients’ blood, 50 control blood SW480, HCT116, CACO2, CACO205, SW620, and LOVO cell lines | Induced EMT | 2016 | Yue et al. [27] |
ADAMTS9-AS1 | - | 59 NT SW116, RKO, HT29, and HCT116 cell lines | Induced EMT | 2020 | Chen et al. [28] |
LINC01194 | CDH2/ VIM | 467 NT HT29, HCT116, and SW620 cell lines | Induced EMT | 2019 | Wang et al. [29] |
SLCO4A1-AS1 | CTNNB1/ GSKb | 50 NT HCT116, HCT8, HT29, LOVO, and SW620 cell lines | Induced EMT | 2018 | Yu et al. [44] |
CYTOR | CTNNB1 | 100 NT HCT116, SW1417, SW620, HT29, CACO2, SW480, and HCT8 cell lines | Induced EMT | 2018 | Yue et al. [45] |
LINC01354 | hnRNP-D/ WNT | 88 NT HCT116, HT29, LOVO, SW620, and SW480 cell lines | Induced EMT | 2019 | Li et al. [46] |
CTD903 | WNT | 115 NT RKO, SW480, SW620, DLD1, CACO2, HCT116, and HT29 cell lines | Suppressed EMT | 2016 | Yuan et al. [48] |
ARAP-AS1 | WNT | 82 NT SW620, SW480, HT29, LOVO, and HCT116 cell lines | Induced EMT | 2019 | Ye et al. [49] |
FOXD2-AS1 | NOTCH | 45 NT RKO, HCT15, HCT28, HCT116, and SW480 cell lines | Induced EMT | 2017 | Yang et al. [63] |
DSCAM-AS1 | miR-137/ NOTCH1 | 51 NT HT29, LOVO, PKO, and SW480 cell lines | Induced EMT | 2020 | Xu et al. [66] |
SLC25A25-AS1 | ERK/ P38 | 30 NT HCT116 and HT29 cell lines | Suppressed EMT | 2016 | Li et al. [79] |
TUG1 | miR-26a-5p/ MMP14/ P38/ HSP27 | SW620, HT29, and CACO2 cell lines | Induced EMT | 2019 | Tian et al. [82] |
NNT-AS1 | MAPK/ ERK | 70 NT SW480 and SW620 cell lines | Induced EMT | 2017 | Wang et al. [83] |
H19 | hnRNPA2B1 | 60 NT HCT116, SW480, and DLD1 | Induced EMT | 2020 | Zhang et al. [85] |
SNHG16 | miR-124-3p/ MCP1 | 120 NT SW480, DLD-1, LOVO, and HCT116 cell lines | Induced EMT | 2020 | Chen et al. [89] |
TUG1 | TWIST1 | 27 NT LOVO, HT29, and HCT116 cell lines | Induced EMT | 2020 | Shen et al. [91] |
SNHG6 | UPF1/ ZEB1 | 77 NT HT29, CACO2, SW480, RKO, SW620, LOVO, and HCT116 cell lines | Induced EMT | 2019 | Wang et al. [93] |
SNHG14 | miR-32-5p/ SKIL | LoVo, RKO, SW480, and HT-29 cell lines | Induced EMT | 2019 | Ye et al. [94] |
PVT1 | miR-216a-5p/ YBX1 | 70 NT LOVO, SW480, HT29, HCT116, and CACO2 cell lines | Induced EMT | 2019 | Zeng et al. [98] |
CASC21 | miR-7-5p/ YAP1 | HT29 and SW480 cell lines | Induced EMT | 2020 | Zheng et al. [108] |
MIR4435-2HG | miR-206/ YAP1 | 90 NT HT-29, SW620, LoVo, and HCT116 cell lines | Induced EMT | 2020 | Dong et al. [109] |
LINC00460 | WWC2 | 62 NT HCT15, HCT116, SW480, SW620, RKO, LOVO, and HT29 cell lines | Induced EMT | 2020 | Yuan et al. [113] |
MALAT1 | EZH2 | 68 NT HT29, SW480, and SW620 cell lines | Induced EMT | 2017 | Li et al. [120] |
SNHG14 | EZH2/EPHA7 | LOVO,SW620, SW480, HCT116, and HT29 cell lines | Induced EMT | 2019 | Di et al. [123] |
XIST | miR-137/ EZH2 | 20 NT LOVO, HT29, and SW620 cell lines | Induced EMT | 2018 | Liu et al. [130] |
B3GALT5-AS1 | miR-203/ ZEB2 | 64 NT HCT116, HT29, LOVO, SW480, and SW620 cell lines | Induced EMT | 2018 | Wang et al. [135] |
HOTAIR | HNF4a | 124 NT HCT116 and HT29 cell lines | Induced EMT | 2021 | Jin et al. [139] |
HOTAIR | CDH1 | 120 NT HT29, SW480, SW620, RKO, HCT116, and LOVO cell lines | Suppressed EMT | 2014 | Wu et al. [140] |
HOXA11-AS1 | miR-149-3p | 105 NT HCT116 cell line | Induced EMT | 2020 | Chen et al. [141] |
EWSAT1 | CDH1 | 106 NT SW480, HT29, and SW620 cell lines | Induced EMT | 2018 | Zhang et al. [143] |
LDLRAD4-AS1 | LDLRAD4/ SNAIL | RKO, LOVO, DLD1, HCT116, HCT8, and HT29 cell lines | Induced EMT | 2020 | Mo et al. [144] |
CHRF | miR-489/ TWIST1 | 80 NT HCT116 and SW480 cell lines | Induced EMT | 2017 | Tao et al. [145] |
KCNQOT1 | miR-217/ ZEB1 | HT29, HCT116, SW480, and DLD1 cell lines | Induced EMT | 2019 | Bian et al. [154] |
ZFAS1 | ZEB1 | 73 NT, 105 patients’ blood, 95 control blood SW620 cell line | Induced EMT | 2017 | Fang et al. [155] |
XIST | miR-200b-3p/ ZEB1 | 115 NT HCT116, HT29, SW620, RKO, SW480, and LOVO cell lines | Induced EMT | 2017 | Chen et al. [156] |
XIST | miR-125b-2-3p | 122 NT DLD1, HCT116, and HCT8 cell lines | Induced EMT | 2021 | Zeng et al. [157] |
TUG1 | miR-138-5p/ ZEB2 | 84 NT LOVO cell line | Induced EMT | 2020 | Yan et al. [158] |
UICLM | miR-215/ ZEB2 | SW620, SW480, LOVO, HT29, HCT116, RKO, and DLD1 cell lines | Induced EMT | 2017 | Chen et al. [161] |
CRCMSL | HMGB2 | HCT116, SW480, SW620, HT29, and LOVO cell lines | Suppressed EMT | 2019 | Han et al. [165] |
CPS1-IT1 | HIF-1α | 24 NT LoVo, SW620, SW480, LS174T, HCT116, and HT29 cell lines | Suppressed EMT | 2017 | Zhang et al. [173] |
XIST | miR-93-5p/ HIF1a | 36 NT SW480 and LOVO cell lines | Induced EMT | 2020 | Yang et al. [174] |